Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
| Autor: | Fuller, Donald B., Falchook, Aaron D., Crabtree, Tami, Kane, Brent L., Medbery, Clinton A., Underhill, Kelly, Gray, James R., Peddada, Anuj, Chen, Ronald C. |
|---|---|
| Zdroj: | In European Urology Oncology December 2018 1(6):540-547 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect